22.07.2019 | Letter to the Editor
Low-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab
Erschienen in: Annals of Hematology | Ausgabe 10/2019
Einloggen, um Zugang zu erhalten